Company page

Nanoviricides, Inc.

Nanoviricides, Inc. is a public company traded under the ticker NNVC in the American market. The company has a market capitalization of approximately $32.2 million. Nanoviricides focuses on developing antiviral therapies to combat various viral infections.

profileNNVC:AMEXAI content: aiUpdated June 24, 2026/company/nanoviricides-inc/c-5mtrgtyx
Nanoviricides, Inc. logo
Ticker
NNVC:AMEX
Asset type
Stock
Market cap
$32.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
AMEX
Currency
USD